Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...
Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...
Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic. If the settlement is finalized, it will ...
Rockville Centre became the first diocese in New York with a confirmed reorganization plan, providing a potential blueprint ...
Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...
Montana will sign onto a proposed national settlement with Purdue Pharma and its owners, the Sackler family, for their role in sparking the opioid crisis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback